Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Patrick G Enright
11 Dec 2025
Director
Buy
5,882
$42.50
$249.99K
Patrick G Enright
24 Jun 2025
Director
Buy indirect
27,071
$22.35
$605.08K
Patrick G Enright
24 Jun 2025
Director
Buy indirect
13,536
$22.35
$302.55K
Patrick G Enright
23 Jun 2025
Director
Buy indirect
139,595
$20.87
$2.91M
Patrick G Enright
23 Jun 2025
Director
Buy indirect
69,798
$20.87
$1.46M
Maha Katabi
30 Jan 2024
Director
Buy indirect
161,290
$31.00
$5.00M
Sean Grant
23 Jun 2023
Chief Financial Officer
Buy indirect
5,000
$16.60
$83.00K
Commodore Capital LP
20 Jun 2023
10% owner
Buy indirect
448,217
$15.17
$6.80M
Beth C Seidenberg
30 Mar 2023
Director
Buy indirect
2,300
$7.24
$16.65K
Beth C Seidenberg
28 Mar 2023
Director
Buy indirect
23,908
$7.24
$173.19K
Beth C Seidenberg
27 Mar 2023
Director
Buy indirect
1,633
$7.24
$11.83K
Beth C Seidenberg
24 Mar 2023
Director
Buy indirect
1,833
$7.24
$13.27K
Beth C Seidenberg
20 Mar 2023
Director
Buy indirect
15,252
$7.21
$110.03K
Beth C Seidenberg
17 Mar 2023
Director
Buy indirect
74,045
$7.12
$526.88K
Beth C Seidenberg
16 Mar 2023
Director
Buy indirect
60,097
$7.09
$426.27K
Beth C Seidenberg
15 Mar 2023
Director
Buy indirect
32,844
$7.12
$234.01K
Beth C Seidenberg
10 Mar 2023
Director
Buy indirect
48,003
$7.16
$343.49K
Beth C Seidenberg
3 Mar 2023
Director
Buy indirect
1,000
$7.25
$7.25K
Beth C Seidenberg
2 Mar 2023
Director
Buy indirect
23,378
$7.24
$169.32K
Beth C Seidenberg
1 Mar 2023
Director
Buy indirect
100
$7.25
$725.00
Beth C Seidenberg
23 Feb 2023
Director
Buy indirect
200
$7.24
$1.45K
Beth C Seidenberg
13 Feb 2023
Director
Buy indirect
10,072
$7.20
$72.49K
Beth C Seidenberg
9 Feb 2023
Director
Buy indirect
400
$7.25
$2.90K
Beth C Seidenberg
8 Feb 2023
Director
Buy indirect
45,357
$7.22
$327.48K
Beth C Seidenberg
7 Feb 2023
Director
Buy indirect
87,956
$7.08
$622.73K
Sofinnova Venture Partners X, L.P.
6 Feb 2023
10% owner
Buy
285,714
$7.00
$2.00M
Patrick G Enright
6 Feb 2023
Director
Buy indirect
1,714,285
$7.00
$12.00M
Longitude Capital Partners IV, LLC
6 Feb 2023
10% owner
Buy indirect
1,714,285
$7.00
$12.00M
Beth C Seidenberg
6 Feb 2023
Director
Buy indirect
131,602
$7.03
$925.16K
Beth C Seidenberg
3 Feb 2023
Director
Buy indirect
46,163
$7.24
$334.22K
Sean Grant
15 Jun 2022
Chief Financial Officer
Buy indirect
992
$13.60
$13.49K
Sean Grant
15 Jun 2022
Chief Financial Officer
Buy indirect
857
$13.60
$11.66K
Sean Grant
15 Jun 2022
Chief Financial Officer
Buy indirect
335
$13.60
$4.56K
Sean Grant
15 Jun 2022
Chief Financial Officer
Buy indirect
2,816
$13.60
$38.30K
Sofinnova Venture Partners X, L.P.
10 Feb 2022
10% owner
Buy
266,666
$15.00
$4.00M
Patrick G Enright
10 Feb 2022
Director
Buy indirect
333,333
$15.00
$5.00M
Longitude Capital Partners IV, LLC
10 Feb 2022
10% owner
Buy indirect
333,333
$15.00
$5.00M
Sean Grant
6 Feb 2022
Chief Financial Officer
Buy
14,285
$7.00
$100.00K
Joseph R Young
6 Feb 2022
SVP, Finance, Chief Acct Offcr
Buy
5,714
$7.00
$40.00K
LLP Abingworth
18 May 2021
10% owner
Buy indirect
772,727
$11.00
$8.50M
Kurt Von Emster
18 May 2021
Director
Buy indirect
772,727
$11.00
$8.50M
Patrick G Enright
18 May 2021
Director
Buy indirect
909,090
$11.00
$10.00M
Maha Katabi
18 May 2021
Director
Buy indirect
727,272
$11.00
$8.00M
Longitude Capital Partners IV, LLC
18 May 2021
10% owner
Buy indirect
909,090
$11.00
$10.00M
Sofinnova Venture Partners X, L.P.
18 May 2021
10% owner
Buy
727,272
$11.00
$8.00M
Kurt Von Emster
17 May 2021
Director
Buy
17,828
$12.04
$214.66K

What was left out

Form 4 filings counted 193
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 139
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 16,126,126
Sales filed before the plan box existed 5
History held since 17 May 2021